[go: up one dir, main page]

CA2005059A1 - Tnf peptides - Google Patents

Tnf peptides

Info

Publication number
CA2005059A1
CA2005059A1 CA002005059A CA2005059A CA2005059A1 CA 2005059 A1 CA2005059 A1 CA 2005059A1 CA 002005059 A CA002005059 A CA 002005059A CA 2005059 A CA2005059 A CA 2005059A CA 2005059 A1 CA2005059 A1 CA 2005059A1
Authority
CA
Canada
Prior art keywords
glu
pro
peptide
gly
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002005059A
Other languages
English (en)
French (fr)
Inventor
Hans-Joachim Boehm
Lothar Daum
Andreas Haupt
Bernhard Schmied
Johann-Christian Zechel
Nigel Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of CA2005059A1 publication Critical patent/CA2005059A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002005059A 1988-12-12 1989-12-11 Tnf peptides Abandoned CA2005059A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3841759.6 1988-12-12
DE3841759A DE3841759A1 (de) 1988-12-12 1988-12-12 Neue tnf-peptide

Publications (1)

Publication Number Publication Date
CA2005059A1 true CA2005059A1 (en) 1990-06-12

Family

ID=6368955

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002005059A Abandoned CA2005059A1 (en) 1988-12-12 1989-12-11 Tnf peptides

Country Status (5)

Country Link
EP (1) EP0447476A1 (de)
JP (1) JPH04502157A (de)
CA (1) CA2005059A1 (de)
DE (1) DE3841759A1 (de)
WO (1) WO1990006945A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258861B2 (en) 1998-08-14 2007-08-21 Innogenetics N.V. TNF-derived peptides for use in treating oedema

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
EP2009023A1 (de) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Neuartige Peptide und ihre Verwendung bei der Behandlung von Ödemen
AT506150B1 (de) * 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Zyklisches und cystein-freies peptid
AT506151B1 (de) 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Fusionsprotein
US20170014472A1 (en) * 2014-03-04 2017-01-19 Apeptico Forschung Und Entwicklung Gmbh Attenuation of intrapulmonary inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258861B2 (en) 1998-08-14 2007-08-21 Innogenetics N.V. TNF-derived peptides for use in treating oedema

Also Published As

Publication number Publication date
WO1990006945A1 (de) 1990-06-28
DE3841759A1 (de) 1990-06-13
EP0447476A1 (de) 1991-09-25
JPH04502157A (ja) 1992-04-16

Similar Documents

Publication Publication Date Title
RU2132334C1 (ru) Аналог долостатина
JP5384342B2 (ja) 癌のような変更された細胞遊走に関連する障害の治療のための薬理学的活性を有するペプチド
US20080090760A2 (en) Compositions and Methods for Inhibiting Cellular Proliferation
JPH07121956B2 (ja) ブラジキニンアンタゴニスト作用を有するペプチド
JP2008534628A (ja) ペプチド誘導体の製造のための方法
CA2005059A1 (en) Tnf peptides
EP1179537B1 (de) Methode festphasensynthese von peptiden
JP2599947B2 (ja) ペプチド化合物
SI9300267A (sl) Novi peptidi, njihova priprava in uporaba za zdravljenje neoplasticnih bolezni
CA2005058A1 (en) Tnf peptides
CA2005050A1 (en) Tnf peptides
US4473555A (en) Nona- and dodecapeptides for augmenting natural killer cell activity
CA2005051A1 (en) Tnf peptides
CA2005060A1 (en) Tnf peptides
US6774211B1 (en) Peptide antiangiogenic drugs
CA2005061A1 (en) Tnf peptides
CA2005052A1 (en) Tnf peptides
CN109248324A (zh) GnRH类似物－抗肿瘤药物偶联物、其制备方法及用途
CA2005281A1 (en) Tnf peptides
AU642487B2 (en) Neutrophil stimulating peptides
US12129312B2 (en) Peptide compound, application thereof and composition containing same
CA2005056A1 (en) Tnf peptides
CA2005057A1 (en) Tnf peptides
WO1993006128A1 (en) Tnf antagonist peptides
EP1370587A2 (de) Antiangiogenische peptide aus endostatin

Legal Events

Date Code Title Description
FZDE Dead